MRWM
NVO

ML&R Wealth Management’s Novo Nordisk NVO Stock Holding History

ML&R Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$630K Sell
4,904
-24
-0.5% -$2.86K 0.14% 35
2023
Q4 		$510K Sell
4,928
-250
-5% -$24.7K 0.12% 42
2023
Q3 		$471K Sell
5,178
-1,000
-16% -$88.1K 0.12% 38
2023
Q2 		$500K Buy
6,178
+24
+0.4% +$1.96K 0.11% 61
2023
Q1 		$490K Buy
+6,154
New +$436K 0.13% 38

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ML&R Wealth Management's NVO Position: Q1 2024 in Review

ML&R Wealth Management reduced its Novo Nordisk (NVO) stake by 0.49% in Q1 2024, selling an estimated $2.86K and leaving 4,904 shares worth $630K. The position accounts for 0.14% of the portfolio, ranked #35.

ML&R Wealth Management first reported a position in NVO in Q1 2023 and has held it in 5 quarters since. 1,744 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

  • ML&R Wealth Management held 4,904 shares of Novo Nordisk worth $630K as of Q1 2024.
  • ML&R Wealth Management sold 24 Novo Nordisk shares in Q1 2024, an estimated $2.86K.
  • Novo Nordisk made up 0.14% of ML&R Wealth Management's portfolio in Q1 2024, its #35 holding.
  • ML&R Wealth Management first reported a position in Novo Nordisk in Q1 2023 and has held it in 5 quarters since.
  • 1,744 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on ML&R Wealth Management's 13F filing for Q1 2024, filed 14 May 2024.